APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Excipients

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchDrug Excipients Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Excipients Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Drug Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Excipients Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Excipients Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Drug Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Excipients include Wacker Chemie, Signet, Roquette, Lubrizol, Kerry, Innophos Holdings, Evonik Industries, Dowdupont and Croda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Excipients Segment by Company

Wacker Chemie

Signet

Roquette

Lubrizol

Kerry

Innophos Holdings

Evonik Industries

Dowdupont

Croda

BASF

Associated British Foods

Ashland

Archer Daniels Midland

Drug Excipients Segment by Type

Organic Chemicals

Inorganic Chemicals

Others

Drug Excipients Segment by Application

Semisolid Drugs

Solid Drugs

Liquid Drugs

Drug Excipients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug Excipients Industry Trends Table 2. Drug Excipients Industry Drivers Table 3. Drug Excipients Industry Opportunities and Challenges Table 4. Drug Excipients Industry Restraints Table 5. Global Drug Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug Excipients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug Excipients Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Drug Excipients Sales Market Share by Manufacturers Table 9. Global Drug Excipients Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Drug Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug Excipients Manufacturers, Product Type & Application Table 13. Global Drug Excipients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Organic Chemicals Table 17. Major Manufacturers of Inorganic Chemicals Table 18. Major Manufacturers of Others Table 19. Global Drug Excipients Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Drug Excipients Sales by Type (2021-2026) & (W Tons) Table 21. Global Drug Excipients Sales by Type (2027-2032) & (W Tons) Table 22. Global Drug Excipients Sales Market Share by Type (2021-2026) Table 23. Global Drug Excipients Sales Market Share by Type (2027-2032) Table 24. Global Drug Excipients Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Drug Excipients Revenue by Type (2021-2026) & (W Tons) Table 26. Global Drug Excipients Revenue by Type (2027-2032) & (W Tons) Table 27. Global Drug Excipients Revenue Market Share by Type (2021-2026) Table 28. Global Drug Excipients Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Semisolid Drugs Table 30. Major Manufacturers of Solid Drugs Table 31. Major Manufacturers of Liquid Drugs Table 32. Global Drug Excipients Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Drug Excipients Sales by Application (2021-2026) & (W Tons) Table 34. Global Drug Excipients Sales by Application (2027-2032) & (W Tons) Table 35. Global Drug Excipients Sales Market Share by Application (2021-2026) Table 36. Global Drug Excipients Sales Market Share by Application (2027-2032) Table 37. Global Drug Excipients Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 38. Global Drug Excipients Revenue by Application (2021-2026) & (W Tons) Table 39. Global Drug Excipients Revenue by Application (2027-2032) & (W Tons) Table 40. Global Drug Excipients Revenue Market Share by Application (2021-2026) Table 41. Global Drug Excipients Revenue Market Share by Application (2027-2032) Table 42. Global Drug Excipients Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Drug Excipients Sales by Region (2021-2026) & (W Tons) Table 44. Global Drug Excipients Sales Market Share by Region (2021-2026) Table 45. Global Drug Excipients Sales Forecasted by Region (2027-2032) & (W Tons) Table 46. Global Drug Excipients Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 48. North America Drug Excipients Sales by Country (2021-2026) & (W Tons) Table 49. North America Drug Excipients Sales by Country (2027-2032) & (W Tons) Table 50. Europe Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 51. Europe Drug Excipients Sales by Country (2021-2026) & (W Tons) Table 52. Europe Drug Excipients Sales by Country (2027-2032) & (W Tons) Table 53. Asia Pacific Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 54. Asia Pacific Drug Excipients Sales by Country (2021-2026) & (W Tons) Table 55. Asia Pacific Drug Excipients Sales by Country (2027-2032) & (W Tons) Table 56. South America, Middle East and Africa Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. South America, Middle East and Africa Drug Excipients Sales by Country (2021-2026) & (W Tons) Table 58. South America, Middle East and Africa Drug Excipients Sales by Country (2027-2032) & (W Tons) Table 59. Global Drug Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Drug Excipients Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Drug Excipients Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Drug Excipients Revenue Market Share by Region (2021-2026) Table 63. Global Drug Excipients Revenue Market Share by Region (2027-2032) Table 64. Wacker Chemie Company Information Table 65. Wacker Chemie Business Overview Table 66. Wacker Chemie Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Wacker Chemie Drug Excipients Product Portfolio Table 68. Wacker Chemie Recent Development Table 69. Signet Company Information Table 70. Signet Business Overview Table 71. Signet Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Signet Drug Excipients Product Portfolio Table 73. Signet Recent Development Table 74. Roquette Company Information Table 75. Roquette Business Overview Table 76. Roquette Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Roquette Drug Excipients Product Portfolio Table 78. Roquette Recent Development Table 79. Lubrizol Company Information Table 80. Lubrizol Business Overview Table 81. Lubrizol Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lubrizol Drug Excipients Product Portfolio Table 83. Lubrizol Recent Development Table 84. Kerry Company Information Table 85. Kerry Business Overview Table 86. Kerry Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Kerry Drug Excipients Product Portfolio Table 88. Kerry Recent Development Table 89. Innophos Holdings Company Information Table 90. Innophos Holdings Business Overview Table 91. Innophos Holdings Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Innophos Holdings Drug Excipients Product Portfolio Table 93. Innophos Holdings Recent Development Table 94. Evonik Industries Company Information Table 95. Evonik Industries Business Overview Table 96. Evonik Industries Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Evonik Industries Drug Excipients Product Portfolio Table 98. Evonik Industries Recent Development Table 99. Dowdupont Company Information Table 100. Dowdupont Business Overview Table 101. Dowdupont Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Dowdupont Drug Excipients Product Portfolio Table 103. Dowdupont Recent Development Table 104. Croda Company Information Table 105. Croda Business Overview Table 106. Croda Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Croda Drug Excipients Product Portfolio Table 108. Croda Recent Development Table 109. BASF Company Information Table 110. BASF Business Overview Table 111. BASF Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. BASF Drug Excipients Product Portfolio Table 113. BASF Recent Development Table 114. Associated British Foods Company Information Table 115. Associated British Foods Business Overview Table 116. Associated British Foods Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Associated British Foods Drug Excipients Product Portfolio Table 118. Associated British Foods Recent Development Table 119. Ashland Company Information Table 120. Ashland Business Overview Table 121. Ashland Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Ashland Drug Excipients Product Portfolio Table 123. Ashland Recent Development Table 124. Archer Daniels Midland Company Information Table 125. Archer Daniels Midland Business Overview Table 126. Archer Daniels Midland Drug Excipients Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Archer Daniels Midland Drug Excipients Product Portfolio Table 128. Archer Daniels Midland Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Drug Excipients Distributors List Table 132. Drug Excipients Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Drug Excipients Product Image Figure 2. Global Drug Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Excipients Sales (2021-2032) & (W Tons) Figure 5. Global Drug Excipients Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Drug Excipients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Organic Chemicals Image Figure 9. Inorganic Chemicals Image Figure 10. Others Image Figure 11. Global Drug Excipients Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Drug Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Drug Excipients Sales Market Share by Type (2021-2032) Figure 14. Global Drug Excipients Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Drug Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Drug Excipients Revenue Market Share by Type (2021-2032) Figure 17. Semisolid Drugs Image Figure 18. Solid Drugs Image Figure 19. Liquid Drugs Image Figure 20. Global Drug Excipients Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Drug Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Drug Excipients Sales Market Share by Application (2021-2032) Figure 23. Global Drug Excipients Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Drug Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Drug Excipients Revenue Market Share by Application (2021-2032) Figure 26. North America Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. North America Drug Excipients Sales Market Share by Country (2021-2032) Figure 28. U.S. Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Canada Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Mexico Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Europe Drug Excipients Sales Market Share by Country (2021-2032) Figure 33. Germany Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. France Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. U.K. Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Italy Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Netherlands Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Asia Pacific Drug Excipients Sales Market Share by Country (2021-2032) Figure 40. China Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Japan Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. South Korea Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Southeast Asia Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. India Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Australia Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South America, Middle East and Africa Drug Excipients Sales Market Share by Country (2021-2032) Figure 48. Brazil Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South Africa Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Saudi Arabia Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Turkey Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Argentina Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. UAE Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Egypt Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Chile Drug Excipients Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Global Drug Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Drug Excipients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Drug Excipients Revenue (2021-2032) & (US$ Million) Figure 59. North America Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Drug Excipients Revenue (2021-2032) & (US$ Million) Figure 61. Europe Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Drug Excipients Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Drug Excipients Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Drug Excipients Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Drug Excipients Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Chemicals
  • Inorganic Chemicals
  • Others
Applications
  • Semisolid Drugs
  • Solid Drugs
  • Liquid Drugs
Companies covered
  • Wacker Chemie
  • Signet
  • Roquette
  • Lubrizol
  • Kerry
  • Innophos Holdings
  • Evonik Industries
  • Dowdupont
  • Croda
  • BASF
  • Associated British Foods
  • Ashland
  • Archer Daniels Midland

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Excipients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug Excipients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug Excipients Market Dynamics
  1. 2.1 Drug Excipients Industry Trends
  2. 2.2 Drug Excipients Industry Drivers
  3. 2.3 Drug Excipients Industry Opportunities and Challenges
  4. 2.4 Drug Excipients Industry Restraints
3 Drug Excipients Market by Manufacturers
  1. 3.1 Global Drug Excipients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug Excipients Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug Excipients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Excipients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug Excipients Manufacturers, Product Type & Application
  7. 3.7 Global Drug Excipients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Excipients Tier 1, Tier 2, and Tier 3
4 Drug Excipients Market by Type
  1. 4.1 Drug Excipients Type Introduction
  2. 4.1.1 Organic Chemicals
  3. 4.1.2 Inorganic Chemicals
  4. 4.1.3 Others
  5. 4.2 Global Drug Excipients Sales by Type
  6. 4.2.1 Global Drug Excipients Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drug Excipients Sales by Type (2021-2032)
  8. 4.2.3 Global Drug Excipients Sales Market Share by Type (2021-2032)
  9. 4.3 Global Drug Excipients Revenue by Type
  10. 4.3.1 Global Drug Excipients Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drug Excipients Revenue by Type (2021-2032)
  12. 4.3.3 Global Drug Excipients Revenue Market Share by Type (2021-2032)
5 Drug Excipients Market by Application
  1. 5.1 Drug Excipients Application Introduction
  2. 5.1.1 Semisolid Drugs
  3. 5.1.2 Solid Drugs
  4. 5.1.3 Liquid Drugs
  5. 5.2 Global Drug Excipients Sales by Application
  6. 5.2.1 Global Drug Excipients Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Excipients Sales by Application (2021-2032)
  8. 5.2.3 Global Drug Excipients Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drug Excipients Revenue by Application
  10. 5.3.1 Global Drug Excipients Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug Excipients Revenue by Application (2021-2032)
  12. 5.3.3 Global Drug Excipients Revenue Market Share by Application (2021-2032)
6 Global Drug Excipients Sales by Region
  1. 6.1 Global Drug Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Drug Excipients Sales by Region (2021-2026)
  4. 6.2.2 Global Drug Excipients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug Excipients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug Excipients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug Excipients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug Excipients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug Excipients Revenue by Region
  1. 7.1 Global Drug Excipients Revenue by Region
  2. 7.1.1 Global Drug Excipients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug Excipients Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug Excipients Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug Excipients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug Excipients Revenue (2021-2032)
  8. 7.2.2 North America Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug Excipients Revenue (2021-2032)
  11. 7.3.2 Europe Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug Excipients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug Excipients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wacker Chemie
  2. 8.1.1 Wacker Chemie Company Information
  3. 8.1.2 Wacker Chemie Business Overview
  4. 8.1.3 Wacker Chemie Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wacker Chemie Drug Excipients Product Portfolio
  6. 8.1.5 Wacker Chemie Recent Developments
  7. 8.2 Signet
  8. 8.2.1 Signet Company Information
  9. 8.2.2 Signet Business Overview
  10. 8.2.3 Signet Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Signet Drug Excipients Product Portfolio
  12. 8.2.5 Signet Recent Developments
  13. 8.3 Roquette
  14. 8.3.1 Roquette Company Information
  15. 8.3.2 Roquette Business Overview
  16. 8.3.3 Roquette Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Drug Excipients Product Portfolio
  18. 8.3.5 Roquette Recent Developments
  19. 8.4 Lubrizol
  20. 8.4.1 Lubrizol Company Information
  21. 8.4.2 Lubrizol Business Overview
  22. 8.4.3 Lubrizol Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lubrizol Drug Excipients Product Portfolio
  24. 8.4.5 Lubrizol Recent Developments
  25. 8.5 Kerry
  26. 8.5.1 Kerry Company Information
  27. 8.5.2 Kerry Business Overview
  28. 8.5.3 Kerry Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kerry Drug Excipients Product Portfolio
  30. 8.5.5 Kerry Recent Developments
  31. 8.6 Innophos Holdings
  32. 8.6.1 Innophos Holdings Company Information
  33. 8.6.2 Innophos Holdings Business Overview
  34. 8.6.3 Innophos Holdings Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Innophos Holdings Drug Excipients Product Portfolio
  36. 8.6.5 Innophos Holdings Recent Developments
  37. 8.7 Evonik Industries
  38. 8.7.1 Evonik Industries Company Information
  39. 8.7.2 Evonik Industries Business Overview
  40. 8.7.3 Evonik Industries Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evonik Industries Drug Excipients Product Portfolio
  42. 8.7.5 Evonik Industries Recent Developments
  43. 8.8 Dowdupont
  44. 8.8.1 Dowdupont Company Information
  45. 8.8.2 Dowdupont Business Overview
  46. 8.8.3 Dowdupont Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dowdupont Drug Excipients Product Portfolio
  48. 8.8.5 Dowdupont Recent Developments
  49. 8.9 Croda
  50. 8.9.1 Croda Company Information
  51. 8.9.2 Croda Business Overview
  52. 8.9.3 Croda Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Croda Drug Excipients Product Portfolio
  54. 8.9.5 Croda Recent Developments
  55. 8.10 BASF
  56. 8.10.1 BASF Company Information
  57. 8.10.2 BASF Business Overview
  58. 8.10.3 BASF Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BASF Drug Excipients Product Portfolio
  60. 8.10.5 BASF Recent Developments
  61. 8.11 Associated British Foods
  62. 8.11.1 Associated British Foods Company Information
  63. 8.11.2 Associated British Foods Business Overview
  64. 8.11.3 Associated British Foods Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Associated British Foods Drug Excipients Product Portfolio
  66. 8.11.5 Associated British Foods Recent Developments
  67. 8.12 Ashland
  68. 8.12.1 Ashland Company Information
  69. 8.12.2 Ashland Business Overview
  70. 8.12.3 Ashland Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ashland Drug Excipients Product Portfolio
  72. 8.12.5 Ashland Recent Developments
  73. 8.13 Archer Daniels Midland
  74. 8.13.1 Archer Daniels Midland Company Information
  75. 8.13.2 Archer Daniels Midland Business Overview
  76. 8.13.3 Archer Daniels Midland Drug Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Archer Daniels Midland Drug Excipients Product Portfolio
  78. 8.13.5 Archer Daniels Midland Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug Excipients Value Chain Analysis
  2. 9.1.1 Drug Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug Excipients Production Mode & Process
  6. 9.2 Drug Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug Excipients Distributors
  9. 9.2.3 Drug Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst